These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34185896)

  • 1. Status Toward the Implementation of Precision Dosing in Children.
    Barrett JS; Barrett RF; Vinks AA
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S36-S51. PubMed ID: 34185896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020.
    Green FG; Park K; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S28-S35. PubMed ID: 34185898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary.
    Wang J; van den Anker JN; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S13-S21. PubMed ID: 34185909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
    Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
    [No Abstract]   [Full Text] [Related]  

  • 5. Model-Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children.
    Vinks AA; Barrett JS
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S52-S59. PubMed ID: 34185897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.
    Polasek TM; Rayner CR; Peck RW; Rowland A; Kimko H; Rostami-Hodjegan A
    Clin Pharmacol Drug Dev; 2019 May; 8(4):418-425. PubMed ID: 30500115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Medicines Agency Experience With Pediatric Dose Selection.
    Manolis E; Musuamba FT; Karlsson KE
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S22-S27. PubMed ID: 34185894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?
    Van Driest SL; Choi L
    Clin Pharmacol Ther; 2019 Jul; 106(1):84-86. PubMed ID: 30942897
    [No Abstract]   [Full Text] [Related]  

  • 9. Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations.
    Tu Q; Cotta M; Raman S; Graham N; Schlapbach L; Roberts JA
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1383-1399. PubMed ID: 34313180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
    Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
    Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
    Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
    Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalised antimicrobial dosing: standing on the shoulders of giants.
    Wallenburg E; Ter Heine R; Schouten JA; Brüggemann RJM
    Int J Antimicrob Agents; 2020 Sep; 56(3):106062. PubMed ID: 32574792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing Recommendations for Pediatric Patients With Renal Impairment.
    Al-Khouja A; Park K; Anderson DJC; Young C; Wang J; Huang SM; Khurana M; Burckart GJ
    J Clin Pharmacol; 2020 Dec; 60(12):1551-1560. PubMed ID: 32542790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.
    Euteneuer JC; Kamatkar S; Fukuda T; Vinks AA; Akinbi HT
    J Clin Pharmacol; 2019 Feb; 59(2):168-176. PubMed ID: 30204236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy.
    Darwich AS; Polasek TM; Aronson JK; Ogungbenro K; Wright DFB; Achour B; Reny JL; Daali Y; Eiermann B; Cook J; Lesko L; McLachlan AJ; Rostami-Hodjegan A
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():225-245. PubMed ID: 33035445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal and Pediatric Dose Selection: Quo Vadis?
    Burckart GJ; van den Anker JN
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S7-S8. PubMed ID: 34185900
    [No Abstract]   [Full Text] [Related]  

  • 19. [Individualized dosing guidelines for children].
    Knibbe CA; Tibboel D; de Wildt SN; de Hoog M; Tjoeng MM; Danhof M
    Ned Tijdschr Geneeskd; 2013; 157(16):A4214. PubMed ID: 23594867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literature.
    Fahmy A; Hopkins AM; Sorich MJ; Rowland A
    Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):803-821. PubMed ID: 34278936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.